Ustekinumab-Aauz 65219-0862-01

Package NDC

65219-0862-01

Manufacturer: Fresenius Kabi Usa, Llc
Dosage Form: Injection, Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: November 15, 2025
Listing Expires: December 31, 2027
Application: BLA761379

Need to source Ustekinumab-Aauz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Ustekinumab	45 mg/.5mL

Drug Class

Interleukin-12 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-12 Antagonist [EPC]

Selected Package

65219-0862-01Selected

1 SYRINGE in 1 CARTON (65219-862-01) / .5 mL in 1 SYRINGE